Story perspectives
New York Mandates Scalp Cooling Coverage for Cancer Patients
11/26/2025
1 of 1
Story summary
- Scalp cooling reduces chemotherapy-induced alopecia, which affects about 65% of cancer patients, by limiting chemotherapy's reach to hair follicles.
- Nancy Vega, a breast cancer patient, joined a Bronx trial to improve scalp cooling for women of color.
- New York will require private insurers to cover scalp cooling starting in January.
- The ongoing study will also explore genetic factors related to chemotherapy-induced alopecia.
